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ENDOCRINOLOGY

Bilateral Adrenal Hemorrhage in a Patient with
Antiphospholipid Syndrome
Silpa Yalamanchili, MD

INTRODUCTION
Bilateral adrenal hemorrhage is relatively uncommon,
with a reported incidence in the United States of 0.3-1.8%
in hospital post-mortems 1.Clinical manifestations of
adrenal hemorrhage are widely variable, making diagnosis
a challenge. Left undiagnosed and untreated, bilateral
adrenal hemorrhage may lead to cardiovascular collapse
and/or death. Here we present a rare case of bilateral
adrenal hemorrhage in a patient with antiphospholipid
syndrome; the aim of this case, and the corresponding
literature review, is to highlight risk factors for and
management of this condition.

CASE PRESENTATION
A 50-year-old woman with recent bilateral knee
replacements developed crampy, diffuse abdominal pain
for two days. The pain was associated with subjective
fevers, nausea, and one episode of non-bloody emesis.
A CT of the abdomen and pelvis done at an outside
facility showed no abnormalities. Due to persistent
symptoms for two days, the patient returned to the
emergency department for evaluation. Her co-morbidities
included antiphospholipid syndrome, prior deep vein
thromboses and pulmonary embolism, recent IVC filter
placement, lupus, and hypertension. She was receiving
maintenance anticoagulation with warfarin for her history
of thromboses with goal INR of 2-3, however admission
labs revealed an INR of 6.61. Initial vitals were significant
for a fever of 100.7ºF, heart rate of 124, and blood
pressure of110/71. Physical examination revealed diffuse
tenderness to palpation on abdominal exam with normal
bowel sounds. No rebound, guarding, flank bruising, or
costovertebral angle tenderness was noted. Admission
labs showed WBC 12.4, Hb 10.8, Plt 68, INR 6.61, Na 124,
K 3.4. Repeat CT of the abdomen and pelvis showed
hyperdensities in both adrenal glands concerning for
bilateral adrenal hemorrhage (Figure 1).

Bilateral adrenal hemorrhage is a rare but potentially fatal
condition. Existing literature suggests that bilateral adrenal
hemorrhage occurs at an incidence of 4.7-6.2 per million
in developed countries.2 However, inadequate detection
and vague clinical presentation often prevents appropriate
and timely management of this condition.

The patient’s warfarin was reversed with Vitamin K 2.5mg
PO as well as Vitamin K 2mg IV, and four units of fresh
frozen plasma. Due to concerns about the development
of adrenal insufficiency, she was started on Hydrocortisone
50mg IV q8hr. The patient was managed supportively,
with no surgical intervention. Her hemoglobin was serially
monitored, and she did not require any blood transfusions.
Due to the patient’s high risk of thrombosis from antiphospholipid syndrome, she was restarted on therapeutic
anticoagulation as soon as she was deemed stable from
a bleeding perspective. Repeat CT scans showed no
continued bleeding. The patient’s subsequent hospital

The exact pathophysiology of adrenal hemorrhage is not
well understood, but case reports suggest that it may
represent a multifactorial etiology. The first theory of the
development of adrenal hemorrhage relates to the
adrenal blood supply. Each adrenal gland is supplied by
50-60 arterioles, which drain into the medullary sinusoids
via relatively few venous channels. Each adrenal gland is
drained by a single central vein, composed of thick
longitudinal muscle, creating increased resistance to flow.
During periods of stress, ACTH hormone is released,
causing an influx of blood flow to the adrenal glands
which may exceed the ability of the singular adrenal vein
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Figure 1. Both adrenal glands are enlarged, oval in shape, and relatively hyperdense.
There is surrounding periadrenal fat stranding bilaterally, more extensive on the left.

course was complicated by thrombocytopenia, septic
shock requiring intubation, ventricular fibrillation cardiac
arrest, and Takutsubo cardiomyopathy. The patient
ultimately recovered after a 28-day hospital stay and was
sent home on a taper of hydrocortisone with instructions
to follow up with hematology and endocrinology. She
was to obtain an outpatient CT abdomen/pelvis four
weeks after discharge to evaluate for resolution of
hemorrhage, however the patient was lost to follow up.

DISCUSSION
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to adequately drain. This may lead to hemorrhage of the
capillaries at the cortico-medullary junction. A second
theory relates to the effect of circulating catecholamines
on the adrenal glands. Catecholamine surge promotes
vasoconstriction and platelet aggregation, which may
induce vasospasm and hemorrhage of the fragile capillary
vessels. A final theory connects adrenal hemorrhage to
arterial thrombosis. Some evidence suggests that the
adrenal vessels are prone to the development of platelet
thrombi and stasis during periods of catecholamine surge.
This outflow obstruction may result in hemorrhage of the
capillary vessels.1 This final theory may account for the
association between antiphospholipid syndrome and
adrenal hemorrhage, and may be the underlying etiology
of hemorrhage in the patient presented in this case report.
The potential causes of adrenal hemorrhage are vast.
Approximately half of all reported cases are associated
with a stressful event or illness. Sepsis, infection, surgery,
blunt trauma, myocardial infarction, heart failure
exacerbation, and pregnancy complications have all been
implicated as precipitants of adrenal hemorrhage. There
is an increased risk in patients on anticoagulation; more
commonly with patients on heparin.3 Thromboembolic
diseases, such as antiphospholipid syndrome or heparin
induced thrombocytopenia, can potentiate the risk of
adrenal hemorrhage as well.4 The patient in this report
presumably developed adrenal hemorrhage as a result of
antiphospholipid syndrome in the setting of a supratherapeutic INR, complicated by sepsis. Less common causes
of adrenal hemorrhage include tuberculosis, amyloidosis,
and metastatic tumors to the adrenal glands.
The most concerning complication of bilateral adrenal
hemorrhage is the development of acute adrenal
insufficiency. If left untreated, adrenal crisis may lead to
critical illness and death. Clinical manifestations of adrenal
insufficiency are typically not noted until 90% of the
adrenal cortex has been destroyed, and insufficiency
does not typically develop in unilateral adrenal
hemorrhage. Death in bilateral adrenal hemorrhage more
often occurs due to the underling precipitating condition
rather than due to the hemorrhage itself, with a mortality
rate as high as 15%.4
Presentation of adrenal hemorrhage is highly variable and
often vague. In 65-85% of published cases, the most
common complaint was nonspecific pain. Pain has been
reported in the epigastrium, flanks, upper and lower back,
pelvis, precordium, and thorax, highlighting the diagnostic
challenge in identifying this condition. Some patients may
present with fatigue, dizziness, arthralgias, anorexia,
nausea, and vomiting, which may be moreso related to
the development of adrenal insufficiency than due to
hemorrhage itself. The most common physical exam
findings associated with adrenal hemorrhage are fever,
tachycardia, and orthostatic hypotension. In rare cases of
meningococcal infection, adrenal insufficiency may
develop as a component of Waterhouse Friderichsen
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syndrome, with an associated maculopapular rash.
Approximately 15-20% of patients show signs of acute
abdomen related to hemorrhage. An estimated 20-40%
of patients may exhibit altered mental status, related to
underlying disease or development of adrenal
insufficiency.1
Workup of adrenal hemorrhage and associated adrenal
insufficiency is limited. As with any bleeding event, serial
hemoglobin monitoring must be performed to screen for
persistent bleeding. A basic metabolic panel may reveal
hyponatremia, hyperkalemia, and prerenal azotemia,
suggesting the presence of adrenal insufficiency. The
absence of these characteristics should not exclude a
diagnosis of adrenal insufficiency in an acutely ill patient
with bilateral adrenal hemorrhage. A baseline cortisol
level may be obtained to stratify patients suspected to
have adrenal insufficiency, or patients requiring additional
cosyntropin stimulation testing. The imaging of choice
for adrenal hemorrhage is CT of the abdomen and pelvis
without contrast. Evidence of adrenal hemorrhage is
evident in areas of higher attenuation (50-60 Hounsfield
units), possibly with surrounding fat stranding or signs of
inflammation. In a patient with confirmed bilateral adrenal
hemorrhage and suspected adrenal insufficiency,
treatment with stress-dosed steroids should not be
delayed while waiting for the results of laboratory testing.
Treatment of bilateral adrenal hemorrhage is directed at
treatment of the hemorrhage itself, and of any resulting
adrenal insufficiency. In the 1990’s, most patients with
adrenal hemorrhage received surgery (adrenalectomies,
adrenal repairs). Current literature endorses supportive
therapy as the mainstay for patients with hemorrhage, as
better outcomes have been observed in patients who do
not undergo surgery.4 This includes serial hemoglobin
measurements, blood transfusions as needed, and fluid
and electrolyte resuscitation. Current recommendations
dictate that if there are no other indications for exploratory
surgery in a trauma patient with adrenal insufficiency,
supportive therapy is preferred if bleeding has stabilized. If
persistent bleeding occurs, patients should be sent for
embolization rather than open surgery. It is imperative to
follow these patients with serial CT imaging to verify
resolution of adrenal hematomas. No absolute recommendations have been made regarding timing of repeat
imaging. Steroid replacement should be initiated with
Hydrocortisone IV 150mg-300mg in divided doses for a
total of 2-3 days. After this period, therapy can be tapered
as tolerated. At higher doses, Hydrocortisone has both
mineralocorticoid and glucocorticoid effects, however,
once the total daily dose of Hydrocortisone is decreased
to 50mg, additional mineralocorticoid therapy should be
given. Many patients recover some, if not all, adrenal
function, and may only require steroid replacement for a
finite length of time. An outpatient cosyntropin test should
be obtained to evaluate for the recovery of adrenal
function.
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